Moderna secures $50M for an mRNA Ebola shot, the U.S. orders a dubious COVID‑19 vaccine, and Russia promises a free personalized cancer vaccine, sparking debate over science, policy, and urgency.
A Texas measles surge and a sea‑cucumber study expose the cost of slashing US disease‑research budgets.
Saint John’s health-tech district tackles regulatory hurdles and public health concerns
Conspiracy theories about hantavirus are spreading online, echoing Covid-19 tactics. Influencers and grifters push baseless claims, sell unproven treatments.
CDC layoffs raise concerns about US ability to respond to infectious disease outbreaks
